featured
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer
N. Engl. J. Med 2020 May 29;[EPub Ahead of Print], K Shitara, YJ Bang, S Iwasa, N Sugimoto, MH Ryu, D Sakai, HC Chung, H Kawakami, H Yabusaki, J Lee, K Saito, Y Kawaguchi, T Kamio, A Kojima, M Sugihara, K YamaguchiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.